Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $441K | +7.18K | +34% | $61.36 | 28.3K | Dec 20, 2021 | Direct | |
transaction | ABBV | Common Stock, $0.01 par value | Sale | -$1.52M | -11.8K | -41.67% | $128.51 | 16.5K | Dec 20, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Option (right to buy) | Options Exercise | -$441K | -7.18K | -100% | $61.36 | 0 | Dec 20, 2021 | Common Stock | 7.18K | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).